Sonoma Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Sonoma Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
Sonoma Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$850K, a 29.6% increase year-over-year.
Sonoma Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$4.28M, a 21.3% increase year-over-year.
Sonoma Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$4.7M, a 2.87% decline from 2022.
Sonoma Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$4.57M, a 22.4% increase from 2021.
Sonoma Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$5.89M, a 70.7% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$4.28M	-$850K	+$358K	+29.6%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	-$4.63M	-$1.17M	+$67K	+5.4%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	-$4.7M	-$1.41M	-$259K	-22.5%	Jan 1, 2024	Mar 31, 2024	10-K	2024-06-17
Q4 2023	-$4.44M	-$844K	+$990K	+54%	Oct 1, 2023	Dec 31, 2023	10-Q	2024-02-08
Q3 2023	-$5.43M	-$1.21M	-$477K	-65.3%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-07
Q2 2023	-$4.96M	-$1.24M	-$385K	-45%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	-$4.57M	-$1.15M	+$1.91M	+62.4%	Jan 1, 2023	Mar 31, 2023	10-K	2024-06-17
Q4 2022	-$6.48M	-$1.83M	-$876K	-91.4%	Oct 1, 2022	Dec 31, 2022	10-Q	2024-02-08
Q3 2022	-$5.61M	-$731K	+$233K	+24.2%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	-$5.84M	-$855K	+$49K	+5.42%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	-$5.89M	-$3.06M	-$246K	-8.74%	Jan 1, 2022	Mar 31, 2022	10-K	2023-06-21
Q4 2021	-$5.64M	-$958K	-$820K	-594%	Oct 1, 2021	Dec 31, 2021	10-Q	2023-02-14
Q3 2021	-$4.82M	-$964K	-$1.13M	-670%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$3.69M	-$904K	-$239K	-35.9%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	-$3.45M	-$2.82M	+$409K	+12.7%	Jan 1, 2021	Mar 31, 2021	10-K	2022-07-13
Q4 2020	-$3.86M	-$138K	+$970K	+87.5%	Oct 1, 2020	Dec 31, 2020	10-Q	2022-02-11
Q3 2020	-$4.83M	$169K	+$1.46M		Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-15
Q2 2020	-$6.28M	-$665K	+$1.11M	+62.5%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-16
Q1 2020	-$7.39M	-$3.22M	-$520K	-19.2%	Jan 1, 2020	Mar 31, 2020	10-K	2021-07-14
Q4 2019	-$6.87M	-$1.11M	+$1.24M	+52.9%	Oct 1, 2019	Dec 31, 2019	10-Q	2021-02-16
Q3 2019	-$8.11M	-$1.29M	+$1.37M	+51.5%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-20
Q2 2019	-$9.48M	-$1.77M	+$1.78M	+50.1%	Apr 1, 2019	Jun 30, 2019	10-Q/A	2020-11-17
Q1 2019	-$11.3M	-$2.7M	+$2.05M	+43.1%	Jan 1, 2019	Mar 31, 2019	10-K	2020-07-10
Q4 2018	-$13.3M	-$2.35M	+$850K	+26.6%	Oct 1, 2018	Dec 31, 2018	10-Q	2020-02-14
Q3 2018	-$14.2M	-$2.65M	+$205K	+7.18%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-14
Q2 2018	-$14.4M	-$3.55M	-$169K	-5%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-13
Q1 2018	-$14.2M	-$4.75M	-$1.84M	-63%	Jan 1, 2018	Mar 31, 2018	10-K	2019-07-01
Q4 2017	-$12.4M	-$3.2M	+$365K	+10.2%	Oct 1, 2017	Dec 31, 2017	10-Q	2019-02-14
Q3 2017	-$12.7M	-$2.86M	+$129K	+4.32%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-08
Q2 2017	-$12.8M	-$3.38M	+$126K	+3.59%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-08
Q1 2017	-$13M	-$2.91M	+$3.44M	+54.2%	Jan 1, 2017	Mar 31, 2017	10-K	2018-06-26
Q4 2016	-$16.4M	-$3.57M	+$624K	+14.9%	Oct 1, 2016	Dec 31, 2016	10-Q	2018-02-14
Q3 2016	-$17M	-$2.99M	-$1.13M	-60.7%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-14
Q2 2016	-$15.9M	-$3.51M	-$1.2M	-51.8%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-08
Q1 2016	-$14.7M	-$6.36M	-$4.7M	-285%	Jan 1, 2016	Mar 31, 2016	10-K	2017-06-28
Q4 2015	-$10M	-$4.19M	-$2.24M	-115%	Oct 1, 2015	Dec 31, 2015	10-Q	2017-02-17
Q3 2015	-$7.77M	-$1.86M	-$314K	-20.3%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-15
Q2 2015	-$7.46M	-$2.31M	-$797K	-52.6%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-09
Q1 2015	-$6.66M	-$1.65M	+$456K	+21.6%	Jan 1, 2015	Mar 31, 2015	10-K	2016-06-21
Q4 2014	-$7.12M	-$1.95M	-$403K	-26.1%	Oct 1, 2014	Dec 31, 2014	10-Q	2016-02-16
Q3 2014	-$6.71M	-$1.54M	-$273K	-21.5%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-10
Q2 2014	-$6.44M	-$1.51M	-$388K	-34.5%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-07
Q1 2014	-$6.05M	-$2.11M	-$726K	-52.5%	Jan 1, 2014	Mar 31, 2014	10-K	2015-06-16
Q4 2013	-$5.33M	-$1.55M	-$866K	-127%	Oct 1, 2013	Dec 31, 2013	10-Q	2015-02-12
Q3 2013	-$4.46M	-$1.27M	-$454K	-55.6%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-13
Q2 2013	-$4.01M	-$1.13M	-$631K	-127%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-12
Q1 2013	-$3.37M	-$1.38M	+$83K	+5.67%	Jan 1, 2013	Mar 31, 2013	10-K	2014-06-30
Q4 2012	-$3.46M	-$680K	+$1.67M	+71.1%	Oct 1, 2012	Dec 31, 2012	10-Q	2014-02-14
Q3 2012	-$5.13M	-$817K	-$187K	-29.7%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-19
Q2 2012	-$4.94M	-$495K	+$1.52M	+75.5%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-14
Q1 2012	-$6.47M	-$1.47M	-$79K	-5.7%	Jan 1, 2012	Mar 31, 2012	10-K	2013-06-25
Q4 2011	-$6.39M	-$2.35M	-$276K	-13.3%	Oct 1, 2011	Dec 31, 2011	10-Q	2013-02-13
Q3 2011	-$6.11M	-$630K	+$1.02M	+61.7%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-08
Q2 2011	-$7.13M	-$2.02M	+$378K	+15.8%	Apr 1, 2011	Jun 30, 2011	10-Q/A	2012-08-31
Q1 2011	-$7.51M	-$1.39M			Jan 1, 2011	Mar 31, 2011	10-K	2012-06-21
Q4 2010		-$2.08M			Oct 1, 2010	Dec 31, 2010	10-Q	2012-02-10
Q3 2010		-$1.65M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-03
Q2 2010		-$2.4M			Apr 1, 2010	Jun 30, 2010	10-Q/A	2011-08-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.